Insightec secures up to $200M for technology development

By staff writers

September 1, 2022 -- MR-guided ultrasound developer Insightec has signed a credit facility for up to $200 million with affiliates of existing shareholders to continue development of its Exablate technology.

The company secured $100 million at closing on September 1, with an additional $100 million of financing potentially available in tranches through 2024.

Insightec's Exablate Neuro system is designed to focus sound waves guided by MRI to target tremors in patients with medication-refractory essential tremor and Parkinson's disease. Research for future applications in the neuroscience space is underway in partnership with leading academic and medical institutions, the company said.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking